https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-chn-a4.pdf
2
需关注的潜在反垄断方面
1.
2.
2.
https://www.avient.com/sites/default/files/2021-09/mevopur-colors-and-additives-for-ivd-devices-application-bulletin-cn.pdf
主要特性
在三个通过ISO 13485认证的医疗生产线生
产全球统一的配方,提供全球一致性和供应
链保障
变更控制记录不限于CAS编号级别,降低变
更风险
不含动物源性物质和邻苯二甲酸盐
可用作各种聚合物的母粒或即用型配方
为方便起见,可在一个产品中实现功能性和颜
色的组合
法规支持
经过预测试的原材料:
- ISO 10993-1
- USP 第、章(VI类)
- USP (指南),6.2.3 可萃取元素;
USP
- ICHQ3D/USP 2 可萃取金属
- 欧洲药典 3.1 聚烯烃(如适用)
FDA发布的注册药品主文件(III类)和/或医疗
器械主文件
为符合(新)法规(如IVDR)的批准或过渡提
供文档支持
适用医疗保健使用限制—见下文。
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
HC_Industry bulletin_PDI_final.indd
www.polymerdiagnostics.com
Industr y Bul let in
Comprehensive consulting and testing
expertise for medical materials and
device companies
Committed to Growing with the Medical Industry
Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical
materials and device clients.
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
www.polymerdiagnostics.com
Industr y Bul let in
Comprehensive consulting and testing
expertise for medical materials and
device companies
Committed to Growing with the Medical Industry
Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical
materials and device clients.
https://www.avient.com/sites/default/files/2020-10/trilliant-xr-product-bulletin.pdf
PRODUCT BULLETIN
PROPERTY TEST METHOD TYPICAL VALUE
(ENGLISH)
TYPICAL VALUE
(SI)
Specific Gravity ASTM D-792 11.0 11.0
Tensile Modulus1 ASTM D-638 1.20E+6 psi 8270 MPa
Tensile Strength1 (Yield) ASTM D-638 3,950 psi 27.2 MPa
Flexural Modulus ASTM D-790 800,000 psi 5520 MPa
Flexural Strength ASTM D-790 7,000 psi 48.3 MPa
Notched Izod Impact2 ASTM D-256A 2.1 ft•lb/in 110 J/m
Deflection Temperature Under Load
66 psi (0.45 MPa), Unannealed,
0.250 in (6.35mm)
ASTM D-648 280°F 138°C
Deflection Temperature Under Load
264 psi (1.8 MPa), Unannealed,
0.250 in (6.35mm)
ASTM D-648 190°F 87.8°C
TECHNICAL PROPERTIES
1 Type I, 0.20 in/min (5.1 mm/min)
2 73°F (23°C), 0.125 in (3.18 mm), Injection molded
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2021-06/colormatrix-oxygen-scavengers-brochure.pdf
PRODUCT RANGE HIGHLIGHTS
Amosorb™ 4020E
• Non-nylon based oxygen scavenging
technology for PET
• Helps to prolong the shelf life of many
products in major markets
Amosorb™ 100
• Non-nylon based oxygen scavenging
technology for PET
• Developed to meet the needs of the
North American market
• Featuring a special additivation package
to allow for pre-consumer regrind
Amosorb™ 4020G
• Lower haze levels and lower impact on PET
recycle stream
• Non-nylon based active oxygen scavenger
• PET and rPET compatible
• Can be used with mono-layer and multi-layer
applications
Amosorb™ 4020R
• Consistent performance with all levels
of rPET (25%, 50% and 100%)
• Improved haze and color when in
combination with rPET
• Flexibility on choice of rPET grade
• Non-nylon based product
Amosorb™ SolO2 -1 (non-carbonated/
carbonated) and SolO2 -2 (carbonated)
• Nylon based oxygen scavenging
technologies for PET
• Active barrier effect to prevent O2 ingress
• Passive barrier effect to prevent gas ingress
and digress from the packaging
(i.e.
https://www.avient.com/sites/default/files/2020-09/antimicrobials-for-electronics-application-bulletin.pdf
They are available
for processes including extrusion, injection
molding, blow molding, rotational molding and
thermoforming.
1. https://www2.deloitte.com/us/en/pages/technology-media-and-
telecommunications/articles/global-mobile-consumer-survey-us-edition.html
2. https://cals.arizona.edu/news/why-your-cellphone-has-more-germs-toilet
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2024-08/Avient Thermoplastic Composite Tapes Product Overview.pdf
KEY FEATURES
• Formulated with 58–80% fiber by weight
• Available in rolls of 25 in/63.4 cm wide
unidirectional tape, slit widths available up
to 2 in/5 cm
• Easily recyclable compared to thermoset
composites
FIBERS FOR POLYSTRAND TAPES
• Fiberglass
THERMOPLASTIC RESINS
• PP
• PE
• PETG
• aPET
• PA6
KEY APPLICATIONS
• Building & Construction
• Automotive
• Consumer & Recreation
• Oil & Gas
PRODUCT BULLETIN
1.844.4AVIENT
www.avient.com
Copyright © 2024, Avient Corporation.
https://www.avient.com/sites/default/files/2021-03/in-house-plastisol-program-bulletin.pdf
SCRAP IS INEVITABLE
• For a company producing 500,000 lbs of plastisol
annually, a 2% scrap rate could equate to $15,000
or more in lost product
https://www.avient.com/sites/default/files/2021-06/sat-avient-de-mexico-sa-de-cv-toluca.pdf
Fijo Lada: 722 Número: 2790200
Página [2] de [3]
Actividades Económicas:
Orden Actividad Económica Porcentaje Fecha Inicio Fecha Fin
1 Otras industrias manufactureras 100 27/08/1999
Regímenes:
Régimen Fecha Inicio Fecha Fin
Régimen General de Ley Personas Morales 01/01/2014
Obligaciones:
Descripción de la Obligación Descripción Vencimiento Fecha Inicio Fecha Fin
Pago provisional mensual de ISR personas morales régimen
general
05/01/1994
Declaración anual de ISR del ejercicio Personas morales.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-de-a4.pdf
Wann immer Sie kartellrechtlich
sensible Aktivitäten mit Auswirkungen innerhalb oder
außerhalb der USA erwarten, sollten Sie sich vorab an
die Rechtsabteilung von Avient wenden.
2
„Angebotsmanipulation“ ist die vorherige
Absprache von Wettbewerbern darüber, wer
während des Ausschreibungsverfahrens das
beste Gebot abgibt und somit den Zuschlag
erhält.
Geschäftsverweigerung - Eine Vereinbarung mit
einem Wettbewerber zum Boykott eines dritten
Unternehmens.
2.
Vermeiden Sie unnötige Kontakte zu Mitbewerbern.
2.